scholarly journals Osteonecrosis and intra-articular fat deposition in a patient with polyarteritis nodosa on high-dose glucocorticoid therapy

2017 ◽  
Vol 12 (1) ◽  
pp. 52 ◽  
Author(s):  
Sumantro Mondal ◽  
RudraProsad Goswami ◽  
Debanjali Sinha ◽  
Geetabali Sircar ◽  
Parasar Ghosh ◽  
...  
2005 ◽  
Vol 113 (08) ◽  
Author(s):  
R Brunner ◽  
D Schaefer ◽  
K Hess ◽  
P Parzer ◽  
F Resch ◽  
...  

2021 ◽  
Vol 14 (3) ◽  
pp. e241431
Author(s):  
Ariana González-Meléndez ◽  
Eduardo J Medina-Parrilla ◽  
Román Vélez ◽  
Luis M Vilá

Polyarteritis nodosa (PAN) is a necrotising systemic vasculitis involving medium-sized and small-sized vessels. PAN limited to a single organ is rare, particularly in the elderly population. Herein, we present a 73-year-old-woman who developed severe abdominal pain. Mesenteric angiography showed multifocal areas of segmental dilation and narrowing of the superior mesenteric, ileocolic and right colonic arteries. Exploratory laparotomy revealed multiple areas of necrosis of the jejunum for which resection was performed. Histopathological exam disclosed mesenteric vasculitis with fibrinoid necrosis of the arterial wall with leucocytic infiltrates and haemorrhages consistent with PAN. She was started on high-dose corticosteroids with an initial good response. However, 6 months later, she developed intestinal pseudo-obstruction for which oral cyclophosphamide was started. After 5 months of cyclophosphamide therapy, she remained stable without further relapses. Our case suggests that PAN should be considered in elderly patients presenting with abdominal pain even in the absence of systemic involvement.


2014 ◽  
Vol 1 (1) ◽  
pp. 13
Author(s):  
Kazu Ode ◽  
Yoshinori Taniguchi ◽  
Yoshitaka Kumon ◽  
Yoshio Terada

We report a case of successful high-dose intravenous immunoglobulin (IVIG) use in a patient with refractory polyarteritis nodosa (PAN). Treatments with prednisolone (PSL) and various types of immunosuppressants including methotrexate (MTX) and intravenous cyclophosphamide (IVCY) were unsuccessful, and then, high-dose IVIG therapy was added. High-dose IVIG therapy improved all symptoms including high fever, arthralgia, mononeuritis multiplex and indurated erythema due to PAN. Moreover, serum inflammatory markers were also normalized. High-dose IVIG is maintaining complete remission for PAN without flare-up for additional 4 years. Therefore, high-dose IVIG therapy might be considered as a first-line therapy in patients with PAN or alternative therapy in refractory PAN.


2006 ◽  
Vol 56 (1) ◽  
pp. 208-214 ◽  
Author(s):  
Frank De Vries ◽  
Madelon Bracke ◽  
Hubert G. M. Leufkens ◽  
Jan-Willem J. Lammers ◽  
Cyrus Cooper ◽  
...  

2005 ◽  
Vol 25 (3) ◽  
pp. 396-398 ◽  
Author(s):  
Yoshihide Asano ◽  
Hironobu Ihn ◽  
Takeo Maekawa ◽  
Takafumi Kadono ◽  
Kunihiko Tamaki

Sign in / Sign up

Export Citation Format

Share Document